Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists

被引:22
|
作者
Campbell, KM [1 ]
McGrath, MJ [1 ]
Burton, FH [1 ]
机构
[1] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
关键词
compulsive behavior; glutamate; obsessive-compulsive disorder (OCD); Tourette's syndrome; catalepsy; (mouse);
D O I
10.1016/S0014-2999(99)00184-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We previously created transgenic mice in which dopamine D-1 receptor-expressing (D1 +) neurons in regional subsets of the cortex and amygdala express a neuropotentiating cholera toxin (CT) transgene. These 'D1CT' mice engage in complex biting, locomotor and behavioral perseverance-repetition abnormalities that resemble symptoms of human compulsive disorders associated with cortical-limbic hyperactivity. Because excessive cortical-limbic stimulation of striatal motor pathways may play a critical role in causing compulsive disorders, we examined the responsiveness of D1CT mice to dopamine D-1 and D-2 receptor antagonists. D1CT mice were found to be largely resistant to the cataleptic action of the D-1 receptor antagonist SCH23390. The abnormal repetitive leaping of D1CT mice was similarly unaffected by SCH23390. In contrast, the DICT mice displayed supersensitivity to cataleptic induction by the D-2 receptor antagonist sulpiride. These data are consistent with the hypothesis that complex compulsions are mediated by chronic excessive corticostriatal (and/or amygdalostriatal) glutamatergic stimulation of the striatal direct and indirect motor pathways. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:103 / 111
页数:9
相关论文
共 50 条
  • [11] EFFECTS OF D1 AND D2 DOPAMINE ANTAGONISTS ON BEHAVIOR OF POLYDIPSIC RATS
    TODD, KG
    BECK, CHM
    MARTINIVERSON, MT
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 42 (03) : 381 - 388
  • [12] Differential effects of dopamine D1 and D2/3 receptor antagonism on motor responses
    Steven Tran
    Magda Nowicki
    Arrujyan Muraleetharan
    Robert Gerlai
    Psychopharmacology, 2015, 232 : 795 - 806
  • [13] Differential effects of dopamine D1 and D2/3 receptor antagonism on motor responses
    Tran, Steven
    Nowicki, Magda
    Muraleetharan, Arrujyan
    Gerlai, Robert
    PSYCHOPHARMACOLOGY, 2015, 232 (04) : 795 - 806
  • [14] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Blasiak, Ewa
    Lukasiewicz, Sylwia
    Szafran-Pilch, Kinga
    Dziedzicka-Wasylewska, Marta
    PHARMACOLOGICAL REPORTS, 2017, 69 (02) : 235 - 241
  • [15] Subpopulations of cortical GABAergic interneurons differ by their expression of D1 and D2 dopamine receptor subtypes
    LeMoine, C
    Gaspar, P
    MOLECULAR BRAIN RESEARCH, 1998, 58 (1-2): : 231 - 236
  • [16] Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor
    Ewa Błasiak
    Sylwia Łukasiewicz
    Kinga Szafran-Pilch
    Marta Dziedzicka-Wasylewska
    Pharmacological Reports, 2017, 69 : 235 - 241
  • [17] Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions
    Broening, HW
    Morford, LL
    Vorhees, CV
    SYNAPSE, 2005, 56 (02) : 84 - 93
  • [18] Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: Differential effects of D1 and D2 receptor antagonists
    Ralph, RJ
    Paulus, MP
    Fumagalli, F
    Caron, MG
    Geyer, MA
    JOURNAL OF NEUROSCIENCE, 2001, 21 (01): : 305 - 313
  • [19] Evidence against dopamine D1/D2 receptor heteromers
    Frederick, A. L.
    Yano, H.
    Trifilieff, P.
    Vishwasrao, H. D.
    Biezonski, D.
    Meszaros, J.
    Urizar, E.
    Sibley, D. R.
    Kellendonk, C.
    Sonntag, K. C.
    Graham, D. L.
    Colbran, R. J.
    Stanwood, G. D.
    Javitch, J. A.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1373 - 1385
  • [20] Dopamine D1–D2 receptor heterodimers: A literature review
    Vekshina N.L.
    Anokhin P.K.
    Veretinskaya A.G.
    Shamakina I.Y.
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2017, 11 (2) : 111 - 119